Contribution of common medications to lower urinary tract symptoms in men
- PMID: 21987200
- PMCID: PMC3351272
- DOI: 10.1001/archinternmed.2011.475
Contribution of common medications to lower urinary tract symptoms in men
Similar articles
-
Editorial: cause and effect of lower urinary tract symptoms.J Urol. 2002 Oct;168(4 Pt 1):1464. doi: 10.1016/S0022-5347(05)64474-6. J Urol. 2002. PMID: 12352418 No abstract available.
-
Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.BJU Int. 1999 Mar;83(4):410-5. doi: 10.1046/j.1464-410x.1999.00966.x. BJU Int. 1999. PMID: 10210562
-
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.J Urol. 1997 Mar;157(3):885-9. J Urol. 1997. PMID: 9072592
-
Benign prostatic hyperplasia.J R Soc Promot Health. 2004 Sep;124(5):222-7. doi: 10.1177/146642400412400519. J R Soc Promot Health. 2004. PMID: 15493782 Review.
-
Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088. J Urol. 2009. PMID: 19846144 Review.
Cited by
-
The relationship between depression, anxiety and lower urinary tract symptoms in men.Prostate Int. 2024 Jun;12(2):86-89. doi: 10.1016/j.prnil.2024.02.002. Epub 2024 Feb 27. Prostate Int. 2024. PMID: 39036760 Free PMC article.
-
Triptorelin therapy for lower urinary tract symptoms (LUTS) in prostate cancer patients: A systematic meta-analysis.BJUI Compass. 2023 Oct 10;5(1):17-28. doi: 10.1002/bco2.292. eCollection 2024 Jan. BJUI Compass. 2023. PMID: 38179030 Free PMC article. Review.
-
Efficacy of Targeted Mast Cell Inhibition Therapy in Chronic Prostatitis/Chronic Pelvic Pain Syndrome.Urology. 2023 Oct;180:200-208. doi: 10.1016/j.urology.2023.05.047. Epub 2023 Jul 12. Urology. 2023. PMID: 37442295 Free PMC article.
-
Efficacy and safety of TURP, HoLEP, and PVP in the management of OAB symptoms complicating BPH in patients with moderately enlarged prostates: A comparative study.Can Urol Assoc J. 2023 Jan;17(1):E1-E7. doi: 10.5489/cuaj.7905. Can Urol Assoc J. 2023. PMID: 36121889 Free PMC article.
-
Antidepressants promote the spread of antibiotic resistance via horizontally conjugative gene transfer.Environ Microbiol. 2022 Nov;24(11):5261-5276. doi: 10.1111/1462-2920.16165. Epub 2022 Aug 25. Environ Microbiol. 2022. PMID: 36054646 Free PMC article.
References
-
- Roehrborn CG, McConnell JD, Barry MJ, et al. AUA Guideline on the Management of Benign Prostatic Hyperplasia. American Urological Association; Baltimore, MD: 2003.
-
- Su L, Guess HA, Girman CJ, et al. Adverse Effects of Medications on Urinary Symptoms and Flow Rate: A Community-Based Study. J Clin Epidemiol. 1996;49:483–487. - PubMed
-
- Khanna OP, Ed Hinman F., Jr. Effect on Nonautonomic Drugs on the Vesical Neck in Benign Prostatic Hypertrophy. Springer-Verlag; New York, NY: 1983. pp. 384–404.
-
- McConnell JD, Barry MJ, Bruskewitz RC, et al. Clinical Practice Guideline. Agency for Health Care Policy and Research; Rockville, MD: 1994. Benign Prostatic Hyperplasia: Diagnosis and Treatment. - PubMed
-
- Wagg A, Andersson KE, Cardozo L, et al. Nocturia: Morbidity and Management in Adults. Int J Clin Pract. 2005;59(8):938–945. - PubMed
